85 related articles for article (PubMed ID: 7497416)
1. The impending Canadian prostate cancer epidemic.
Morrison HI; MacNeill IB; Miller D; Levy I; Xie L; Mao Y
Can J Public Health; 1995; 86(4):274-8. PubMed ID: 7497416
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer trends in Canada: rising incidence or increased detection?
Levy IG; Gibbons L; Collins JP; Perkins DG; Mao Y
CMAJ; 1993 Sep; 149(5):617-24. PubMed ID: 8364818
[TBL] [Abstract][Full Text] [Related]
3. The changing age distribution of prostate cancer in Canada.
Neutel CI; Gao RN; Blood PA; Gaudette LA
Can J Public Health; 2007; 98(1):60-4. PubMed ID: 17278680
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer incidence and mortality rates and trends in the United States and Canada.
McDavid K; Lee J; Fulton JP; Tonita J; Thompson TD
Public Health Rep; 2004; 119(2):174-86. PubMed ID: 15192905
[TBL] [Abstract][Full Text] [Related]
5. Dramatic increase in prostate cancer cases by 2021.
Quon H; Loblaw A; Nam R
BJU Int; 2011 Dec; 108(11):1734-8. PubMed ID: 21507185
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer mortality in New Zealand: the past and projections for the future.
Cohen RJ; Robinson E; McRae CU
Aust N Z J Surg; 1997 Nov; 67(11):781-4. PubMed ID: 9396994
[TBL] [Abstract][Full Text] [Related]
7. An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?
Feletto E; Bang A; Cole-Clark D; Chalasani V; Rasiah K; Smith DP
World J Urol; 2015 Nov; 33(11):1677-87. PubMed ID: 25698456
[TBL] [Abstract][Full Text] [Related]
8. Current and projected rates of hip fracture in Canada.
Papadimitropoulos EA; Coyte PC; Josse RG; Greenwood CE
CMAJ; 1997 Nov; 157(10):1357-63. PubMed ID: 9371065
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer--testing, incidence, surgery and mortality.
Gibbons L; Waters C
Health Rep; 2003 May; 14(3):9-20. PubMed ID: 12816012
[TBL] [Abstract][Full Text] [Related]
10. The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L
CMAJ; 2000 Apr; 162(7):977-83. PubMed ID: 10763395
[TBL] [Abstract][Full Text] [Related]
11. Incidence and Mortality of Prostate Cancer in Canada during 1992-2010.
Lagacé F; Ghazawi FM; Le M; Savin E; Zubarev A; Powell M; Moreau L; Sasseville D; Popa I; Litvinov IV
Curr Oncol; 2021 Feb; 28(1):978-990. PubMed ID: 33617514
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.
Pina F; Castro C; Ferro A; Bento MJ; Lunet N
Eur J Cancer Prev; 2017 Sep; 26(5):404-410. PubMed ID: 27483413
[TBL] [Abstract][Full Text] [Related]
13. Monograph series on aging-related diseases: X. Prostate cancer.
Ellison LF; Stokes J; Gibbons L; Lindsay J; Levy I; Morrison H
Chronic Dis Can; 1998; 19(1):1-18. PubMed ID: 9550730
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer: 1. The descriptive epidemiology in Canada.
Levy IG; Iscoe NA; Klotz LH
CMAJ; 1998 Sep; 159(5):509-13. PubMed ID: 9757178
[TBL] [Abstract][Full Text] [Related]
15. The role of increasing detection in the rising incidence of prostate cancer.
Potosky AL; Miller BA; Albertsen PC; Kramer BS
JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
[TBL] [Abstract][Full Text] [Related]
16. [Estimates and prediction of prostate cancer incidence, mortality and prevalence in China, 2008].
Peng P; Gong YM; Bao PP; Ke JZ; Xiang YM; Zhang ML; Zheng Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1056-9. PubMed ID: 23290851
[TBL] [Abstract][Full Text] [Related]
17. Quebec prostate cancer mortality dropped in 1996.
Meyer F; Moore L; Bairati I; Fradet Y
Cancer Prev Control; 1998 Aug; 2(4):163-6. PubMed ID: 10093628
[TBL] [Abstract][Full Text] [Related]
18. Trends in death rates and registration rates for prostate cancer in England and Wales.
Majeed FA; Burgess NA
Br J Urol; 1994 Apr; 73(4):377-81. PubMed ID: 8199825
[TBL] [Abstract][Full Text] [Related]
19. [Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990].
Grosclaude P; Menegoz F; Schaffer P; Macé Lesec'h J; Arveux P; Le Mab G; Soulié M; Villers A
Prog Urol; 1997 Sep; 7(4):647-54. PubMed ID: 9410328
[TBL] [Abstract][Full Text] [Related]
20. Does testing for prostate-specific antigen contribute to declining prostate cancer mortality? Estimating the broader economic influences on aggregate prostate cancer mortality rates.
Di Matteo L; Di Matteo R
Eur J Health Econ; 2005 Dec; 6(4):298-308. PubMed ID: 16180027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
